Scolaris Content Display Scolaris Content Display

Study flow diagram.
Figuras y tablas -
Figure 1

Study flow diagram.

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 2

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Summary of findings for the main comparison. Summary of findings for the main comparison: cough augmentation techniques versus no cough augmentation technique

Cough augmentation techniques compared with no cough augmentation techniques for critically‐ill, mechanically‐ventilated adults and children

Patient or population: critically‐ill mechanically‐ventilated adults and children requiring extubation from mechanical ventilation

Settings: High acuity setting including ICUs, weaning centres, respiratory intermediate care units, and high‐dependency units in Europe and North America

Intervention: Cough augmentation techniques including lung volume recruitment, manually‐assisted cough and mechanical insufflation‐exsufflation

Comparison: No cough augmentation

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

No cough augmentation

Cough augmentation

Extubation successa

87%

83%

RR 1.58 (1.13 to 2.20)

75 participants
1 trial

⊕⊝⊝⊝
very low1

Duration of mechanical ventilationb

4 days

11.7 days

Mean difference ‐6.1 days (‐8.4 to ‐3.8)

75 participants
1 trial

⊕⊝⊝⊝
very low1

ICU mortalitya

28%

0%

Not calculable, as no event rates in the 1 trial reporting data on this outcome

75 participants
1 trial

⊕⊝⊝⊝
very low1

Adverse events

1. Hypotensionc

2. Hypertensiond

3. Secretion encumbrance resulting in severe hypoxaemia requiring reintubationc

12%

6.5%

9%

3%

10%

6%

RR 3.4 (0.1 to 81.3)

RR 3.0 (0.1 to 65.9)

RR 0.25 (0.1 to 1.1)

75 participants
1 trial

20 participants

1 trial

75 participants
1 trial

⊕⊝⊝⊝
very low2

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk Ratio

aAssumed risk is derived from a large international cohort study of mechanical ventilation and weaning by Esteban 2013 and refers to the rate of reintubation reported in this study.

bAssumed risk is derived from a large international cohort study of mechanical ventilation and weaning by Esteban 2008.

cAssumed risk is derived from adverse events (hypotension and hypoxaemia) reported in a systematic review of recruitment manoeuvres in people with acute lung injury (Fan 2008).

dAssumed risk is derived from rates of hypertension noted during 6691 episodes of endotracheal suctioning (Evans 2014).

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1We based our downgrading decisions from high to very low on unclear risk of bias, inability to assess consistency or publication bias, and uncertainty about the estimate of effect due to the limited number of studies contributing outcome data.

2We based our downgrading decisions from high to very low on unclear risk of bias, inability to assess consistency or publication bias, imprecision due to wide confidence intervals, and uncertainty about the estimate of effect due to the limited number of studies contributing outcome data.

We have not included reintubation or weaning success in the 'Summary of findings' table as no studies reported these outcomes.

Figuras y tablas -
Summary of findings for the main comparison. Summary of findings for the main comparison: cough augmentation techniques versus no cough augmentation technique
Table 1. Table of secondary outcomes

Cough augmentation

No cough augmentation

Study

N

mean (SD)

N

mean (SD)

mean difference

95% CIs

Duration of mechanical ventilation (days)

Gonçalves 2012

35

11.7 (3.5)

40

17.8 (6.4)

‐6.1

‐8.4 to ‐3.8

ICU length of stay (days)1

Gonçalves 2012

35

16.9 (11.1)

40

19.3 (8.1)

‐2.4

‐6.9 to 2.01

Niranjan 1998

10

47.6 (7.3)

7

51.1 (7.8)

‐3.5

‐10.8 to 3.8

1The ICU length of stay for cases reported in Niranjan 1998 includes the four cases that were not intubated at the start of the study.

Figuras y tablas -
Table 1. Table of secondary outcomes
Table 2. Adverse effects

Cough augmentation

No cough augmentation

Study

Events

Total

Events

Total

RR

95% CIs

Haemodynamic compromise

Gonçalves 2012

1

35

0

40

3.4

0.1 to 81.3

Crowe 2006

1

10

0

10

3.0

0.1 to 65.9

Secretion encumbrance resulting in severe hypoxaemia requiring reintubation

Gonçalves 2012

2

35

9

40

0.25

0.1 to 1.1

Figuras y tablas -
Table 2. Adverse effects